UNIVERSITY OF ZIMBABWE

UZ gains government support for biotechnology advancements, aligning with Vision 2030's goals of health security and agricultural resilience. The UZ Biotechnology Center, supported by PACMAN and AFD, showcased tools for managing agricultural and public health challenges, emphasizing local capacity-building and self-reliance.

Prof Gift Matope discusses the UZ Biotechnology Centre Laboratory's capabilities in diagnosing, monitoring, and controlling infectious diseases.

Prof. Collen Masimirembwa leads the first multinational pharmacogenomics study in Africa, aiming to optimize treatments based on genetic makeup. The study involves 6,000 patients from Nigeria, Kenya, Zimbabwe, and South Africa, and is part of the Consortium for Genomics & Therapeutics in Africa (CGTA). Masimirembwa's work has pioneered pharmacogenomics in Africa, leading to the development of genetic tests like GenoPharm, which are being used to improve treatment outcomes.